Haijun Dong Becomes Chief Executive Officer of BioDuro-Sundia

BioDuro-Sundia has hired Haijun Dong, PhD, MBA as Chief Executive Officer. He joins from PharmaBlock Sciences, where he led as Chief Executive Officer. Prior to that, he served as Chief Operating Officer for Eli Lilly China R&D Company. Haijun succeeds Cyrus K. Mirsaidi in the company’s top leadership role while Cyrus remains with the company in an Advisor capacity.

BioDuro-Sundia is a leading contract research, development and manufacturing organization (CRDMO) that provides biopharmaceutical partners with fully integrated services to support drug discovery, development and manufacturing for both drug substance and drug product. The San Diego, CA-based company has more than 2,000 employees and10 global sites.